Evidence map›Paper›PMID 19924535›Full record

ArticleDigestive diseases and sciences2010

Comparison of the effect of azithromycin versus erythromycin on antroduodenal pressure profiles of patients with chronic functional gastrointestinal pain and gastroparesis.

Baharak Moshiree, Renee McDonald, Wei Hou, Phillip P Toskes

Registry-linked trialAbstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03840057 (Metoclopramide, Azithromycin, or Nondrug Pretreatment for Upper Gastrointestinal Bleeding to Reduce Second Endoscopy), which is not on this map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03840057 phase2unknown statusnot on this mapstarted 2020, after this paper: background citation

Metoclopramide, Azithromycin, or Nondrug Pretreatment for Upper Gastrointestinal Bleeding to Reduce Second Endoscopy

TypeinterventionalSponsorWaihong ChungRan2020 to 2021Enrolled435ConditionsGastro Intestinal Bleeding, Upper Gastrointestinal BleedingArmsAzithromycin Injection, Metoclopramide Injectable Solution, Sodium chloride 0.9%
3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 102 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Safety and Efficacy of Oral Azithromycin for Gastrointestinal Dysmotility in Pediatric Patients.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Diabetic Gastroparesis.Endocrine reviews · 2019
    Review
  10. Article
  11. Review
  12. Review
  13. Diabetic gastroparesis: current challenges and future prospects.Clinical and experimental gastroenterology · 2018
    Review
  14. Review
  15. Novel Diet, Drugs, and Gastric Interventions for Gastroparesis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2016
    Review
  16. Review
  17. Review
  18. Article
  19. Antitussive drugs--past, present, and future.Pharmacological reviews · 2014
    Review
  20. Gastrointestinal motility disorders in children.Gastroenterology & hepatology · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Baharak MoshireeDivision of Gastroenterology, Hepatology and Nutrition, University of Florida, Gainesville, FL 32610, USA. moshib@medicine.ufl.edu
Renee McDonald
Wei Hou
Phillip P Toskes
University of Florida · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCurrent pharmacologic treatments for gastroparesis have been disappointing due to the limited options available. Erythromycin ethylsuccinate is a potent prokinetic agent that stimulates gastric emptying. Recently, erythromycin has been linked to the occurrences of sudden cardiac death due to QT prolongation. Azithromycin is similar to erythromycin in structure but does not have significant drug-drug interactions as seen with erythromycin. PURPOSE: This study aims to determine whether azithromycin stimulates antral activity in patients with chronic gastrointestinal pain and refractory gastroparesis.

methodsSmall bowel manometric data on 30 patients undergoing clinical evaluation for chronic digestive problems or documented refractory gastroparesis were reviewed. Antral activity was measured after infusion of erythromycin 250 mg intravenous and azithromycin (500 or 250 mg intravenous) given at different intervals during the small bowel manometry. The parameters measured included the total duration of effect, mean amplitude of antral contractions, duration of the highest antral contraction phase, number of cycles per minute, and the motility index.

resultsComparison of erythromycin and azithromycin at similar doses showed a similar positive effect on antral activity. However, comparison of erythromycin and azithromycin at the higher dose of 500 mg showed that the mean amplitude, duration of antral activity, and motility index were significantly increased with azithromycin (P < 0.05).

conclusionsAzithromycin stimulates antral activity similar to erythromycin and moreover has a longer duration of effect. However, unlike erythromycin, azithromycin does not have significant drug-drug interactions and maybe a potential new medication for the treatment of gastroparesis and gastrointestinal dysmotility.

Indexed as

Abdominal PainAdultAgedAnti-Bacterial AgentsAzithromycinChronic DiseaseErythromycin EthylsuccinateFemaleGastrointestinal AgentsGastrointestinal MotilityGastroparesisHumansMaleManometryMiddle AgedPyloric AntrumAnti-Bacterial AgentsAzithromycinErythromycin EthylsuccinateGastrointestinal Agents

Identifiers

PMID19924535
OpenAlexW2072385472

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.